Dr. Sara Sarwar Riaz, MD

Dr. Riaz practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Riaz's NPI, 1215192729, was assigned on July 23, 2008. Dr. Riaz holds Michigan license 4301091645.

Dr. Riaz's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Riaz's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Riaz is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Riaz to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Riaz practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Riaz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Riaz is licensed in Michigan.

CMS data shows 1,851 Medicare services from Dr. Riaz across 7 procedure codes in 2024, for 495 Medicare patients. Medicare paid $155,812 for them.

CMS counts 495 Medicare patients who saw Dr. Riaz in 2024. The largest group is 75 to 84, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Riaz's median patient age at 73, with 60% women.

In 2024, Dr. Riaz wrote 653 Medicare Part D claims for 114 patients. 70% of them were for generic drugs. CMS names the drug for 365 of them, across 17 drugs with 11 or more claims each, at $1,850,357 in total drug cost. In 2023, CMS named 357 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Riaz for performance year 2024, reported as part of a group. Dr. Riaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Riaz as offering telehealth.

CMS Open Payments shows 110 general payments to Dr. Riaz from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $267.